APC and cancer: This experiment is required because of the unexpected result displayed by apcin, where it displayed great promise as an APC/CCdc20-specific inhibitor, but, unfortunately, also disrupts the function of the MCC, thus allowing cancer cells to still execute ‘mitotic slippage’ by entering anaphase, even in the presence of a mitotic poison [24].